On March 27, 2024, the Italian Ministry of Health issued a circular outlining prevention and immunization measures against Respiratory Syncytial Virus (RSV).
“Respiratory Syncytial Virus (RSV) is a highly transmissible virus that causes annual epidemics during autumn and winter seasons in temperate climates. RSV infection is the leading cause of bronchiolitis and thus of hospitalization in infants under one year of age. It is also a major cause of acute respiratory infections (ARIs), asthmatic bronchitis/asthma in children, adolescents, and young adults, as well as exacerbations of chronic obstructive pulmonary disease (COPD) in adults and the elderly, and interstitial pneumonia with acute respiratory distress syndrome (ARDS) in older adults, particularly in the presence of comorbidities (such as chronic pulmonary, cardiac, cerebrovascular, or renal diseases, and other immunocompromising conditions).”
This is stated in the circular issued by Francesco Vaia, General Director of Prevention, detailing the prevention and immunization measures against Respiratory Syncytial Virus (RSV).
References
Virus sinciziale. Dai fattori di rischio ai vaccini. Arriva circolare del Ministero della Salute con le misure di prevenzione – Quotidiano Sanità. (s.d.). QS – Quotidiano Sanità. https://www.quotidianosanita.it/governo-e-parlamento/articolo.php?articolo_id=121232&fr=n
